🧬

Age & Use Verification

You must be 21+ to enter this site.

All products discussed on this site are Research Use Only (RUO) compounds intended strictly for laboratory research. Nothing here is medical advice, and these products are not for human or veterinary use.

Exit

We use cookies for analytics and to improve your experience. See our disclosure.

Cerebrolysin: Research Profile, Dosages & Supplier Prices

Neuropeptide research · Aqueous solution (multi-peptide complex) · Also known as: Cere, FPF 1070

Cerebrolysin is a neuropeptide research compound with a molecular weight of <10 kDa fraction and a research half-life of hours (component-dependent). Cerebrolysin is not a single peptide but a standardized, enzymatically prepared mixture of low-molecular-weight neurotrophic peptides and free amino acids derived from purified porcine brain tissue. Developed in Austria, it has been used clinically in parts of Europe and Asia for decades and studied in stroke, traumatic brain injury, vascular dementia and Alzheimer's disease trials.

Research Use Only (RUO). Not for human or veterinary use. Not medical advice.

SequenceProprietary mixture of low-molecular-weight neurotrophic peptides (<10 kDa) derived from purified porcine brain proteins
FormulaPeptide mixture
Mol. weight<10 kDa fraction
Half-lifeHours (component-dependent)
Forms soldAqueous solution (multi-peptide complex)

What is Cerebrolysin?

Its research interest lies in multimodal neurotrophic activity: components mimic aspects of endogenous neurotrophic factor signaling (BDNF, GDNF, NGF-like activity), supporting neuronal survival, synaptic plasticity and neurogenesis in animal models. Because it is a biological mixture rather than a defined synthetic peptide, batch consistency and manufacturer provenance matter more than for any other compound in this catalog - genuine pharmaceutical Cerebrolysin is produced only by EVER Neuro Pharma.

Mechanism of Action (Research Context)

Multimodal: neurotrophic factor-mimetic signaling supporting neuronal survival and differentiation, reduced excitotoxicity, modulation of neuroinflammation, and promotion of synaptic plasticity and neurogenesis observed in animal models.

Research Areas

Stroke recovery modelsTraumatic brain injuryAlzheimer's and vascular dementia researchNeurotrophic factor signalingSynaptic plasticity

Cerebrolysin Dosages in Research

5ml ampoules10ml ampoules

Clinical studies used 10-30 ml daily intravenously for multi-week courses. Sold as research material in ampoule form. Research-context only.

Dosage information is a summary of published laboratory research and is provided for informational purposes only. These compounds are not for human use.

Storage & Handling

Ampoules: room temperature or 2-8C per manufacturer, protected from light. Do not freeze. Use immediately once opened.

Cerebrolysin Supplier Price Comparison

No tracked suppliers stock Cerebrolysin yet — inventory syncs run continuously. Check our supplier reviews.

Cerebrolysin FAQ

No - it is a standardized mixture of low-molecular-weight peptides (<10 kDa) and amino acids prepared from porcine brain proteins. There is no single sequence or molecular weight.
Stroke recovery, traumatic brain injury, vascular dementia and Alzheimer's disease. It has one of the largest clinical trial bodies of any neurotrophic preparation, though results remain debated.
Authentic product is manufactured only by EVER Neuro Pharma (Austria). Because it is a biological mixture, HPLC fingerprinting rather than a single mass-spec peak is used for identity - provenance of supply is the key check.
🧬

Before you go —

Get weekly supplier alerts, price-drop notifications, and COA updates. Plus our featured pick: Certified Pep.